Todd Hricik

Memorial Sloan Kettering Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index6.5kcitations41works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(18), Acute Myeloid Leukemia Research(16), Myeloproliferative Neoplasms: Diagnosis and Treatment(11), Chronic Myeloid Leukemia Treatments(7), Cancer Genomics and Diagnostics(7)

Publications41 total

Data from Chromatin Structure Predicts Epigenetic Therapy Responsiveness in Sarcoma
2023Open Access
Supplementary Figures 1 - 15, Tables 1 - 2 from JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
2023Open Access
Data from JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
2023Open Access
Supplementary Figures 1 - 15, Tables 1 - 2 from JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
2023Open Access
Data from JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
2023Open Access
Data from Chromatin Structure Predicts Epigenetic Therapy Responsiveness in Sarcoma
2023Open Access
Supplementary Figures 1-11, Supplementary Tables 1-2 from Chromatin Structure Predicts Epigenetic Therapy Responsiveness in Sarcoma
2023Open Access
Supplementary Figures 1-11, Supplementary Tables 1-2 from Chromatin Structure Predicts Epigenetic Therapy Responsiveness in Sarcoma
2023Open Access
Using RAPIDS AI to Accelerate Graph Data Science Workflows
2020· 16 cited
Genomic Landscapes in Elderly AML
Blood·2017· 1 cited
Changes of the Mutational Landscape in Relapsed Acute Myeloid Leukemia
Blood·2016
Abstract LB-073: Epigenome evolution in relapsed acute myeloid leukemia
Cancer Research·2016
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Nature Medicine·2016· 393 citedOpen Access
Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
Nature Medicine·2016· 10 cited
Divergent Dynamics of Epigenetic and Genetic Heterogeneity in Relapsed Acute Myeloid Leukemia
Blood·2015· 3 cited
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
eLife·2015· 170 citedOpen Access
Author response: Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
2015· 1 citedOpen Access
Loss of BAP1 function leads to EZH2-dependent transformation
Nature Medicine·2015· 392 citedOpen Access
Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
Cancer Cell·2015· 242 citedOpen Access
The Polycomb Group Protein L3MBTL1 Represses a SMAD5-Mediated Hematopoietic Transcriptional Program in Human Pluripotent Stem Cells
Stem Cell Reports·2015· 7 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Ross L. Levine(29), Omar Abdel‐Wahab(17), Ari Melnick(13), Raajit K. Rampal(10), Christopher Y. Park(8), Stephen D. Nimer(7), Franck Rapaport(7), Christopher E. Mason(7), Anna Sophia McKenney(7), Alan H. Shih(6), Xinyang Zhao(6), Martin Carroll(6), Iannis Aifantis(6), Francine E. Garrett-Bakelman(6), Jay Patel(6), Priya Koppikar(6), Neha Bhagwat(6), Sachie Marubayashi(6), Maria Kleppe(6), Franziska Michor(6)